ACTAVIS MID ATLANTIC FDA Approval ANDA 078976

ANDA 078976

ACTAVIS MID ATLANTIC

FDA Drug Application

Application #078976

Documents

Letter2009-01-21

Application Sponsors

ANDA 078976ACTAVIS MID ATLANTIC

Marketing Status

Prescription001

Application Products

001SOLUTION;ORAL100MG/ML0LEVETIRACETAMLEVETIRACETAM

FDA Submissions

ORIG1AP2009-01-15
REMS; REMSSUPPL3AP2010-02-16
LABELING; LabelingSUPPL4AP2010-11-17
LABELING; LabelingSUPPL6AP2014-09-26STANDARD
LABELING; LabelingSUPPL9AP2014-09-26STANDARD
LABELING; LabelingSUPPL11AP2014-09-26STANDARD
LABELING; LabelingSUPPL13AP2014-09-26STANDARD

Submissions Property Types

SUPPL3Null7
SUPPL6Null7
SUPPL9Null15
SUPPL11Null15
SUPPL13Null15

TE Codes

001PrescriptionAA

CDER Filings

ACTAVIS MID ATLANTIC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 78976
            [companyName] => ACTAVIS MID ATLANTIC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LEVETIRACETAM","activeIngredients":"LEVETIRACETAM","strength":"100MG\/ML","dosageForm":"SOLUTION;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"LEVETIRACETAM","submission":"LEVETIRACETAM","actionType":"100MG\/ML","submissionClassification":"SOLUTION;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.